Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmen C Sucharov

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Future Cardiology|October 7, 2009
Role of p38MAPK in beta(2)AR-induced cardiomyopathy: at the heart of the matter?Carmen C Sucharov
Expert Review of Cardiovascular Therapy|November 19, 2005
Gene expression and heart failure. 24-27 July 2005, 2nd Annual Symposium of the American Heart Association Council on Basic Cardiovascular Sciences, Keystone, CO, USACarmen C Sucharov
JACC. Basic to Translational Science|March 7, 2020
Paracrine Factors in Uremic CardiomyopathyCarmen C Sucharov
Expert Review of Cardiovascular Therapy|December 26, 2006
Beta-adrenergic pathways in human heart failureCarmen C Sucharov
Journal of Cardiovascular Development and Disease|September 19, 2017
Midkine's Role in Cardiac PathologyKathleen C Woulfe, Carmen C Sucharov
The Journal of Cardiovascular Aging|July 24, 2023
The secretome as a biomarker and functional agent in heart failureObed O Nyarko, Carmen C Sucharov
Non-Coding RNA Investigation|September 11, 2018
CELF1 regulates gap junction integrity contributing to dilated cardiomyopathyDanielle A Jeffrey, Carmen C Sucharov
European Heart Journal|May 1, 2023
Big tau aggregation and the broken heartObed O Nyarko, Carmen C Sucharov
American Journal of Physiology. Heart and Circulatory Physiology|March 29, 2020
Dysregulated micro-RNAs and long noncoding RNAs in cardiac development and pediatric heart failureLee S Toni, Frehiwet Hailu, Carmen C Sucharov
Molecular Biology of the Cell|July 18, 2008
YY1 protects cardiac myocytes from pathologic hypertrophy by interacting with HDAC5Carmen C Sucharov, Karen Dockstader, Timothy A McKinsey
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Future Cardiology|October 7, 2009
Role of p38MAPK in beta(2)AR-induced cardiomyopathy: at the heart of the matter?Carmen C Sucharov
Expert Review of Cardiovascular Therapy|November 19, 2005
Gene expression and heart failure. 24-27 July 2005, 2nd Annual Symposium of the American Heart Association Council on Basic Cardiovascular Sciences, Keystone, CO, USACarmen C Sucharov
JACC. Basic to Translational Science|March 7, 2020
Paracrine Factors in Uremic CardiomyopathyCarmen C Sucharov
Expert Review of Cardiovascular Therapy|December 26, 2006
Beta-adrenergic pathways in human heart failureCarmen C Sucharov
Journal of Cardiovascular Development and Disease|September 19, 2017
Midkine's Role in Cardiac PathologyKathleen C Woulfe, Carmen C Sucharov
The Journal of Cardiovascular Aging|July 24, 2023
The secretome as a biomarker and functional agent in heart failureObed O Nyarko, Carmen C Sucharov
Non-Coding RNA Investigation|September 11, 2018
CELF1 regulates gap junction integrity contributing to dilated cardiomyopathyDanielle A Jeffrey, Carmen C Sucharov
European Heart Journal|May 1, 2023
Big tau aggregation and the broken heartObed O Nyarko, Carmen C Sucharov
American Journal of Physiology. Heart and Circulatory Physiology|March 29, 2020
Dysregulated micro-RNAs and long noncoding RNAs in cardiac development and pediatric heart failureLee S Toni, Frehiwet Hailu, Carmen C Sucharov
Molecular Biology of the Cell|July 18, 2008
YY1 protects cardiac myocytes from pathologic hypertrophy by interacting with HDAC5Carmen C Sucharov, Karen Dockstader, Timothy A McKinsey
Pageof 9